Kidney Failure, Chronic: Clinical Trials

2,011 trials for Kidney Failure, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1226 completed, 291 unknown, 134 recruiting, 134 terminated. 762 Not applicable, 273 Phase 2, 236 Phase 4, 196 Phase 3, 182 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable762Completed 448, Unknown 112, Recruiting 54, Terminated 53, Not yet recruiting 36, Active not recruiting 32, Withdrawn 21, Enrolling by invitation 5, Suspended 1
Phase 2273Completed 166, Unknown 32, Terminated 31, Recruiting 18, Withdrawn 10, Not yet recruiting 7, Active not recruiting 6, Enrolling by invitation 2, Suspended 1
Phase 4236Completed 146, Unknown 40, Terminated 18, Withdrawn 12, Active not recruiting 8, Recruiting 7, Not yet recruiting 3, Enrolling by invitation 1, Suspended 1
Phase 3196Completed 131, Unknown 23, Terminated 16, Recruiting 10, Active not recruiting 6, Withdrawn 6, Not yet recruiting 3, Suspended 1
Phase 1182Completed 125, Recruiting 18, Unknown 12, Terminated 11, Active not recruiting 7, Not yet recruiting 6, Withdrawn 3
Early Phase 110Completed 7, Withdrawn 2, Recruiting 1

Follow Kidney Failure, Chronic: new trials by email Literature Review of Kidney Failure, Chronic trials Research Report on Kidney Failure, Chronic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
PATH-03 Paraguay Feasibility Study
ePATH System will be used to create an endoAVF - Kidney Disease, End-Stage
Not applicableNot yet recruitingPathfinder Medical202027-03-012026-09-17
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
Bupropion Hydrochloride 150 MG - End Stage Renal Disease, Fatigue
Phase 1 / Phase 2Not yet recruitingThe University of Texas Health Science Center at San Antonio162027-02-012026-11-02
Drone Transport of Deceased-Donor Kidney Grafts Between Two French Hospitals Before Transplantation: a Pilot Safety Study
Kidney graft transport by autonomous unmanned aircraft (drone) between the procurement and transplantation centres - Kidney Failure, Chronic, Kidney Transplantation
Not applicableNot yet recruitingNantes University Hospital52027-01-152026-10-01
Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
Standard Table Salt, Salt Substitute - End Stage Kidney Disease
Not applicableNot yet recruitingNYU Langone Health202027-01-152026-03-12
Effect of Resistance Exercise in Hemodialysis Patients
Resistance Exercise Training - Hemodialysis
Not applicableNot yet recruitingAssiut University1042027-01-152026-11-13
Microbiota Changes Related to Outcomes in Kidney Transplantation
Fecal samples, Urinary sample, Blood samples - End-stage Renal Disease (ESRD), Kidney Transplantation
Not yet recruitingHospices Civils de Lyon302027-01-012026-10-26
Virtual Reality-Guided Imagery in Hemodialysis Patients ( VRGI-HD )
virtual reality-guided imagery (VRGI) - End-Stage Kidney Disease (ESKD)
Not applicableNot yet recruitingIslamic University of Najaf802027-01-012026-10-09
Hypothermic Kidney Machine Perfusion With Omnisol
Omnisol organ preservation solution - End Stage Renal Disease (ESRD), Kidney Transplant
Not applicableNot yet recruitingVivalyx GmbH162027-01-012026-11-10
Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.
Spironolactone (drug), Iron Supplement, Erythropoietin stimulating agent - Anemia
Phase 2Not yet recruitingAin Shams University402026-12-012026-07-20
Acupuncture for Symptom Burden and Quality of Life in Patients With End-Stage Kidney Disease
Acupuncture, Sham Acupuncture - End Stage Kidney Disease (ESKD)
Not applicableNot yet recruitingUniversity General Hospital of Heraklion1602026-12-012026-10-21
Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring
Continuous Glucose Monitoring (CGM) - End Stage Kidney Disease (ESKD), Hyperglycaemia
Not yet recruitingEmory University1802026-12-012026-10-27
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)
Eliquis, No oral anticoagulation - Atrial Fibrillation, Atrial Flutter
Phase 3Not yet recruitingUnity Health Toronto8482026-11-012026-08-21
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
GGTA1 KO Thymokidney - ESRD (End-Stage Renal Disease), Kidney Transplantation
Phase 1 / Phase 2RecruitingUnited Therapeutics502026-11-012026-09-09
Ramipril vs. Amlodipine in Pediatric Hemodialysis Patients
Ramipril tablet, Amlodipine tablet - Endothelial Dysfunction, End-Stage Renal Disease
Phase 3Not yet recruitingAin Shams University502026-11-012026-10-21
Comparative Feasibility and Effectiveness of Medically Tailored Meals Approaches for Pediatric End-Stage Kidney Disease
Culinary Medicine Intervention, Pre-prepared MTMs - End Stage Kidney Disease (ESKD)
Not applicableNot yet recruitingBaylor College of Medicine302026-11-012026-11-03
Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
ChoironeX GalKO Porcine Thymokidney - End Stage Renal Disease
Phase 1RecruitingXeno Holdings (US), LLC dba ChoironeX42026-11-012026-11-10
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
Target systolic blood pressure <120 mmHg., Target systolic blood pressure <140 mmHg - End Stage Kidney Disease (ESKD), Hypertension (HTN)
Not applicableRecruitingUniversity of California, San Francisco102026-10-302026-11-06
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on Hemodialysis
INCB161734 - Renal Insufficiency, Kidney Diseases
Phase 1Not yet recruitingIncyte Corporation242026-10-262026-10-02

Showing 20 of 2011. Sign in to see all of them.

Narrower conditions

Renal Insufficiency, Chronic (328)  ·  Renal Insufficiency (171)  ·  Kidney Diseases (110)  ·  Anemia (80)  ·  Cardiovascular Diseases (60)  ·  Arteriovenous Fistula (49)  ·  Diabetes Mellitus (49)  ·  Inflammation (45)  ·  Motor Activity (41)  ·  Acute Kidney Injury (40)  ·  Hyperphosphatemia (37)  ·  Heart Failure (36)  ·  Hyperparathyroidism, Secondary (36)  ·  Hypertension (33)

Broader conditions

Disease Attributes (2011)  ·  Female Urogenital Diseases (2011)  ·  Female Urogenital Diseases and Pregnancy Complications (2011)  ·  Male Urogenital Diseases (2011)  ·  Pathologic Processes (2011)  ·  Pathological Conditions, Signs and Symptoms (2011)  ·  Urogenital Diseases (2007)  ·  Chronic Disease (2004)  ·  Urologic Diseases (2004)  ·  Kidney Diseases (1901)  ·  Renal Insufficiency (1840)  ·  Renal Insufficiency, Chronic (1683)  ·  Nutritional and Metabolic Diseases (245)  ·  Cardiovascular Diseases (206)  ·  Metabolic Diseases (202)

Interventions

Tacrolimus (31)  ·  Exercise (28)  ·  Epoetin Alfa (23)  ·  Mycophenolic Acid (23)  ·  Renal Dialysis (23)  ·  Blood Specimen Collection (21)  ·  Kidney Transplantation (17)  ·  Sirolimus (15)  ·  hematide (15)  ·  paricalcitol (15)  ·  peginesatide (15)  ·  Cinacalcet (14)  ·  Sevelamer (14)  ·  Cholecalciferol (12)  ·  Cyclosporine (12)

Sponsors

Vantive Health LLC (30)  ·  National Taiwan University Hospital (24)  ·  Amgen (20)  ·  University of Washington (17)  ·  Emory University (16)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (16)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (16)  ·  Satellite Healthcare (16)  ·  University of Pennsylvania (16)  ·  Vanderbilt University (15)  ·  Assiut University (14)  ·  Fresenius Medical Care Deutschland GmbH (13)  ·  Johns Hopkins University (13)  ·  Rockwell Medical Technologies, Inc. (13)  ·  Affymax (12)

Countries

United States (749)  ·  France (137)  ·  Canada (125)  ·  Germany (107)  ·  United Kingdom (101)  ·  China (98)  ·  Italy (74)  ·  Spain (66)  ·  Taiwan (66)  ·  South Korea (61)  ·  Belgium (60)  ·  Australia (46)  ·  Brazil (46)  ·  Poland (46)  ·  Turkey (Türkiye) (44)

Top investigators

Alp Ikizler, MD (12)  ·  Mohammad Ali Tabibi, Dr (8)  ·  Vice President, Clinical Development (8)  ·  Joel Melnick, MD (7)  ·  Jonathan Himmelfarb, MD (6)  ·  Wael F Hussein, MBBS (6)  ·  Adrian Ebner, MD (5)

Results publications

PMID 40576086, PMID 35018639, PMID 33586138, PMID 36005278, PMID 32390133, PMID 35224730, PMID 37651553, PMID 33283264, PMID 36791280, PMID 37916745, PMID 38189593, PMID 36472416, PMID 23343061, PMID 23343062, PMID 32446407, PMID 32734207, PMID 36039153, PMID 37870148, PMID 38899545, PMID 39498822, PMID 19558344, PMID 27587605, PMID 36472884, PMID 37968132, PMID 38363466, PMID 39037824, PMID 15213282, PMID 16008588, PMID 19339093, PMID 20721651, PMID 21564530, PMID 22422538, PMID 23137211, PMID 23149295, PMID 23332990, PMID 23970131, PMID 24011252, PMID 25136843, PMID 25293374, PMID 26175145, PMID 26288091, PMID 26463883, PMID 26718625, PMID 27203778, PMID 28094031, PMID 28301073, PMID 28506446, PMID 28767349, PMID 28910799, PMID 29621747

NIH funding

2019 (7), 2023 (7), 2015 (6), 2005 (5), 2008 (5), 2014 (5), 2004 (4), 2009 (3), 2018 (3), R01DK045604 (3), 2016 (2), 2017 (2), 2025 (2), R01AG006244 (2), R01NR004340 (2)